These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21195945)

  • 1. The REPEAT study: recognizing and evaluating periodic local reactions in allergen immunotherapy and associated systemic reactions.
    Calabria CW; Stolfi A; Tankersley MS
    Ann Allergy Asthma Immunol; 2011 Jan; 106(1):49-53. PubMed ID: 21195945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy.
    Calabria CW; Coop CA; Tankersley MS
    J Allergy Clin Immunol; 2009 Oct; 124(4):739-44. PubMed ID: 19767075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy.
    Roy SR; Sigmon JR; Olivier J; Moffitt JE; Brown DA; Marshall GD
    Ann Allergy Asthma Immunol; 2007 Jul; 99(1):82-6. PubMed ID: 17650835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction.
    Kelso JM
    Ann Allergy Asthma Immunol; 2004 Feb; 92(2):225-7. PubMed ID: 14989390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local reactions from subcutaneous allergen immunotherapy.
    Coop CA
    Immunotherapy; 2013 Dec; 5(12):1339-45. PubMed ID: 24283844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local reactions during allergen immunotherapy do not require dose adjustment.
    Tankersley MS; Butler KK; Butler WK; Goetz DW
    J Allergy Clin Immunol; 2000 Nov; 106(5):840-3. PubMed ID: 11080704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose adjustment practices among allergists for local reactions to immunotherapy.
    Coop CA; Tankersley MS
    Ann Allergy Asthma Immunol; 2007 Jul; 99(1):77-81. PubMed ID: 17650834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient perceptions regarding local reactions from allergen immunotherapy injections.
    Coop CA; Tankersley MS
    Ann Allergy Asthma Immunol; 2008 Jul; 101(1):96-100. PubMed ID: 18681091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic reactions associated with subcutaneous allergen immunotherapy: timing and risk assessment.
    DaVeiga SP; Liu X; Caruso K; Golubski S; Xu M; Lang DM
    Ann Allergy Asthma Immunol; 2011 Jun; 106(6):533-537.e2. PubMed ID: 21624754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GILL study: glycerin-induced local reactions in immunotherapy.
    Calabria CW; Coop CA; Tankersley MS
    J Allergy Clin Immunol; 2008 Jan; 121(1):222-6. PubMed ID: 17919703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System.
    Cox L; Larenas-Linnemann D; Lockey RF; Passalacqua G
    J Allergy Clin Immunol; 2010 Mar; 125(3):569-74, 574.e1-574.e7. PubMed ID: 20144472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are large local reactions a marker for systemic reactions to subcutaneous immunotherapy in children?
    Simsek IE; Aydogan M
    Asian Pac J Allergy Immunol; 2022 Mar; 40(1):75-80. PubMed ID: 34246207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side-effects of injective allergen immunotherapy administered to intermittent or persistent allergic rhinitis patients.
    Rogala B; Markiewicz-Bendkowska IB; Brzoza Z; Glück J; Oleś E
    Rhinology; 2007 Jun; 45(2):134-9. PubMed ID: 17708460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.
    Bukantz SC; Bagg AS; Lockey RF
    Clin Allergy Immunol; 2008; 21():455-68. PubMed ID: 18828523
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence and characteristics of biphasic reactions after allergen immunotherapy.
    Scranton SE; Gonzalez EG; Waibel KH
    J Allergy Clin Immunol; 2009 Feb; 123(2):493-8. PubMed ID: 19064282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the safety of subcutaneous immunotherapy dose adjustments.
    Webber CM; Calabria CW
    Ann Allergy Asthma Immunol; 2010 Nov; 105(5):369-75. PubMed ID: 21055663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of an unusual cluster of systemic reactions to subcutaneous specific immunotherapy with respiratory allergens in one allergy center.
    Scherer K; Schindler C; Arnold A; Bach S; Bircher AJ
    Int Arch Allergy Immunol; 2012; 157(3):318-20. PubMed ID: 22056648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-fatal systemic reactions to subcutaneous immunotherapy: a 20-year experience comparison of two 10-year periods.
    Ragusa VF; Massolo A
    Eur Ann Allergy Clin Immunol; 2004 Feb; 36(2):52-5. PubMed ID: 15061395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.